RSS

CYDY CytoDyn Inc

Last Post: 10/16/26
Followers: 439
Posts Today: 0
Views Today: 29670

CYDY Stock Quote & Tools

$0.2283 ▲ +0.0229 (+11.14%) As of Oct 16, 3:59 PM EDT
Last0.2283
$ Chg0.0229
Open0.2050
High0.2300
Beta1.4964
Year High0.397
Market Cap335.42M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.68M
Volume3.96M
% Chg+11.14%
Prev Close0.2054
Low0.2050
VWAP0.21542
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences

CYDY Stock Message Board Discussion

  1. PTM1
  2. Figgs
  3. MicMac
  4. TonyCorvette

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

SAVE Act: A Potential Game Changer for Americans Abroad

Updated Category News Views 204

Understanding the Impact of the SAVE Act on Expats As U.S. expats grapple with the complexities of taxation and representation, recent developments surrounding the SAVE Act prompt a crucial conversation. MyExpatTaxes, a leader in providing tax services to Americans abroad, has brought attention to the implications of this bill for millions of U.S. citizens living outside...

Continue Reading
U.K. Stock Market Sees Gains as Key Indexes Rise Today

Updated Category News Views 184

U.K. Stock Market Overview The U.K. stock market closed on a positive note, showing promising signs across various indices. This is an encouraging moment for investors, particularly as shares from major sectors like mining, automobiles, and beverages have played a significant role in this upward trend. Insights into Sector Performance Recent analysis reveals that the...

Continue Reading
Insights on Outlook Therapeutics' Upcoming Webinar Presentation

Updated Category News Views 113

Key Presentation by Outlook Therapeutics at Upcoming Webinar Outlook Therapeutics, Inc. (NASDAQ: OTLK), a notable biopharmaceutical company known for its innovative approach in treating retinal diseases, has exciting news to share. The company has achieved remarkable milestones in the healthcare sector, particularly with its ophthalmic formulation of bevacizumab, a...

Continue Reading
Anglo American Moves Forward with $3.8 Billion Coal Sale

Updated Category News Views 163

Anglo American's Strategic Sale of Coal Portfolio Anglo American has made a significant decision to divest its Australian steelmaking coal portfolio, selling it to Peabody Energy for a total consideration of up to $3.8 billion. This transaction is part of Anglo American's broader strategy to pivot towards more sustainable and future-facing commodities. Details of the...

Continue Reading
Flow Traders Reflects on Trading Environment for 2025 Q1

Updated Category News Views 301

Flow Traders Review of Trading Environment for Q1 2025 Welcome to the summary of Flow Traders' recent insights as presented by Eric Pan, the Head of Investor Relations. During the pre-close call for the first quarter of 2025, significant trends and data points were discussed that shape our understanding of the financial markets today. Insightful data was shared that not...

Continue Reading